Mitchell L. Shiffman - Publications, H-index & Citations

Mitchell L. Shiffman

James J. Peters VA Medical Center

97H指数

402论文数

5.4W被引数

收录论文 216

发表时间

Cholate Shunt, Oral Cholate Challenge and Endoscopic Lesions of Portal Hypertension: The SHUNT-V Study

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2024-11-10

OAAI

Shiffman, Mitchell; Reddy, K. Rajender; Leise, Michael D.; Qureshi, Kamran; Smith, Alastair D.; Helmke, Steve; Kittelson, John; Mcrae, Michael P.; Imperial, Joanne C.; Everson, Gregory T.

Role of Pre-Operative TIPS in Patients Undergoing Surgery

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2024-10-01

PREAI

Shiffman, Mitchell L.

Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis Elafibranor在原发性胆汁性胆管炎中的疗效和安全性

NEW ENGLAND JOURNAL OF MEDICINE

IF78.5

2024-02-29

PREAI

Kowdley, Kris V.; Bowlus, Christopher L.; Levy, Cynthia; Akarca, Ulus S.; Alvares-da-Silva, Mario Reis; Andreone, Pietro; Arrese, Marco; Corpechot, Christophe; Francque, Sven M.; Heneghan, Michael A.; Invernizzi, Pietro; Jones, David; Kruger, Frederik C.; Lawitz, Eric; Mayo, Marlyn J.; Shiffman, Mitchell L.; Swain, Mark G.; Valera, Jose Miguel; Vargas, Victor; Vierling, John M.; Villamil, Alejandra; Addy, Carol; Dietrich, Julie; Germain, Jean-Michel; Mazain, Sarah; Rafailovic, Dragutin; Tadde, Bachirou; Miller, Benjamin; Shu, Jianfen; Zein, Claudia O.; Schattenberg, Jorn M.

Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis 开放标签，临床试验扩展: seladelpar在原发性胆汁性胆管炎患者中的两年安全性和有效性结果

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2023-10-30

OAAI

Mayo, Marlyn J.; Vierling, John M.; Bowlus, Christopher L.; Levy, Cynthia; Hirschfield, Gideon M.; Neff, Guy W.; Galambos, Michael R.; Gordon, Stuart C.; Borg, Brian B.; Harrison, Stephen A.; Thuluvath, Paul J.; Goel, Aparna; Shiffman, Mitchell L.; Swain, Mark G.; Jones, David E. J.; Trivedi, Palak; Kremer, Andreas E.; Aspinall, Richard J.; Sheridan, David A.; Doerffel, Yvonne; Yang, Ke; Choi, Yun-Jung; McWherter, Charles A.

Safety and Sustained Efficacy of the Farnesoid X Receptor (FXR) Agonist Cilofexor Over a 96-Week Open-label Extension in Patients With PSC 法尼醇X受体 (FXR) 激动剂Cilofexor在PSC患者中进行96周开放标签扩展的安全性和持续疗效

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY

IF12

2023-06-01

PREAI

Trauner, Michael; Bowlus, Christopher L.; Gulamhusein, Aliya; Hameed, Bilal; Caldwell, Stephen H.; Shiffman, Mitchell L.; Landis, Charles; Muir, Andrew J.; Billin, Andrew; Xu, Jun; Liu, Xiangyu; Lu, Xiaomin; Chung, Chuhan; Myers, Robert P.; V. Kowdley, Kris

Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study

HEPATOLOGY

IF15.8

2023-04-06

OAAI

Hirschfield, Gideon M.; Shiffman, Mitchell L.; Gulamhusein, Aliya; Kowdley, Kris, V; Vierling, John M.; Levy, Cynthia; Kremer, Andreas E.; Zigmond, Ehud; Andreone, Pietro; Gordon, Stuart C.; Bowlus, Christopher L.; Lawitz, Eric J.; Aspinall, Richard J.; Pratt, Daniel S.; Raikhelson, Karina; Gonzalez-Huezo, Maria S.; Heneghan, Michael A.; Jeong, Sook-Hyang; Ladron de Guevara, Alma L.; Mayo, Marlyn J.; Dalekos, George N.; Drenth, Joost P. H.; Janczewska, Ewa; Leggett, Barbara A.; Nevens, Frederik; Vargas, Victor; Zuckerman, Eli; Corpechot, Christophe; Fassio, Eduardo; Hinrichsen, Holger; Invernizzi, Pietro; Trivedi, Palak J.; Forman, Lisa; Jones, David E. J.; Ryder, Stephen D.; Swain, Mark G.; Steinberg, Alexandra; Boudes, Pol F.; Choi, Yun-Jung; McWherter, Charles A.

A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis 原发性胆汁性胆管炎患者seladelpar的II期，随机，开放标签，为期52周的研究

JOURNAL OF HEPATOLOGY

IF33

2022-08-01

OAAI

Bowlus, Christopher L.; Galambos, Michael R.; Aspinall, Richard J.; Hirschfield, Gideon M.; Jones, David E. J.; Doerffel, Yvonne; Gordon, Stuart C.; Harrison, Stephen A.; Kremer, Andreas E.; Mayo, Marlyn J.; Thuluvath, Paul J.; Levy, Cynthia; Swain, Mark G.; Neff, Guy W.; Sheridan, David A.; Stanca, Carmen M.; Berg, Christoph P.; Goel, Aparna; Shiffman, Mitchell L.; Vierling, John M.; Boudes, Pol; Steinberg, Alexandra; Choi, Yun-Jung; McWherter, Charles A.

A Pragmatic, Randomized Controlled Trial of Oral Antivirals for the Treatment of Chronic Hepatitis C: The PRIORITIZE Study

HEPATOLOGY

IF15.8

2021-12-01

OAAI

Sulkowski, Mark S.; Moon, Juhi S.; Sherman, Kenneth E.; Morelli, Giuseppe; Darling, Jama M.; Muir, Andrew J.; Khalili, Mandana; Fishbein, Dawn A.; Hinestrosa, Federico; Shiffman, Mitchell L.; Di Bisceglie, Adrian; Rajender Reddy, K.; Pearlman, Brian; Lok, Anna S.; Fried, Michael W.; Stewart, Paul W.; Peter, Joy; Wadsworth, Summer; Kixmiller, Scott; Sloan, Anquenette; Vainorius, Monika; Horne, Patrick M.; Michael, Larry; Dong, Meichen; Evon, Donna M.; Segal, Jodi B.; Nelson, David R.

A Machine Learning Approach to Liver Histological Evaluation Predicts Clinically Significant Portal Hypertension in NASH Cirrhosis 用于肝组织学评估的机器学习方法可预测NASH肝硬化中具有临床意义的门静脉高压

HEPATOLOGY

IF15.8

2021-12-01

OAAI

Bosch, Jaime; Chung, Chuhan; Carrasco-Zevallos, Oscar M.; Harrison, Stephen A.; Abdelmalek, Manal F.; Shiffman, Mitchell L.; Rockey, Don C.; Shanis, Zahil; Juyal, Dinkar; Pokkalla, Harsha; Le, Quang Huy; Resnick, Murray; Montalto, Michael; Beck, Andrew H.; Wapinski, Ilan; Han, Ling; Jia, Catherine; Goodman, Zachary; Afdhal, Nezam; Myers, Robert P.; Sanyal, Arun J.

Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis

HEPATOLOGY COMMUNICATIONS

IF4.6

2021-05-12

OAAI

Younossi, Zobair M.; Stepanova, Maria; Noureddin, Mazen; Kowdley, Kris V.; Strasser, Simone I.; Kohli, Anita; Ruane, Peter; Shiffman, Mitchell L.; Sheikh, Aasim; Gunn, Nadege; Caldwell, Stephen H.; Huss, Ryan S.; Myers, Robert P.; Wai-Sun Wong, Vincent; Alkhouri, Naim; Goodman, Zachary; Loomba, Rohit

Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH 包括Cilofexor和Firsocostat在内的联合疗法可桥接NASH引起的纤维化和肝硬化

HEPATOLOGY

IF15.8

2021-02-15

185

PREAI

Loomba, Rohit; Noureddin, Mazen; Kowdley, Kris V.; Kohli, Anita; Sheikh, Aasim; Neff, Guy; Bhandari, Bal Raj; Gunn, Nadege; Caldwell, Stephen H.; Goodman, Zachary; Wapinski, Ilan; Resnick, Murray; Beck, Andrew H.; Ding, Dora; Jia, Catherine; Chuang, Jen-Chieh; Huss, Ryan S.; Chung, Chuhan; Subramanian, G. Mani; Myers, Robert P.; Patel, Keyur; Borg, Brian B.; Ghalib, Reem; Kabler, Heidi; Poulos, John; Younes, Ziad; Elkhashab, Magdy; Hassanein, Tarek; Iyer, Rajalakshmi; Ruane, Peter; Shiffman, Mitchell L.; Strasser, Simone; Wong, Vincent Wai-Sun; Alkhouri, Naim

Role of Noninvasive Tests in Clinical Gastroenterology Practices to Identify Patients With Nonalcoholic Steatohepatitis at High Risk of Adverse Outcomes: Expert Panel Recommendations

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2020-12-07

OAAI

Younossi, Zobair M.; Noureddin, Mazen; Bernstein, David; Kwo, Paul; Russo, Mark; Shiffman, Mitchell L.; Younes, Ziad; Abdelmalek, Manal

Cilofexor, a NonsteroidalFXRAgonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial Cilofexor，一种非类固醇醛酮受体激动剂，用于非肝硬化NASH患者: 一项2期随机对照试验

HEPATOLOGY

IF15.8

2020-07-14

245

PREAI

Patel, Keyur; Harrison, Stephen A.; Elkhashab, Magdy; Trotter, James F.; Herring, Robert; Rojter, Sergio E.; Kayali, Zeid; Wong, Vincent Wai-Sun; Greenbloom, Susan; Jayakumar, Saumya; Shiffman, Mitchell L.; Freilich, Bradley; Lawitz, Eric J.; Gane, Edward J.; Harting, Eliza; Xu, Jun; Billin, Andrew N.; Chung, Chuhan; Djedjos, C. Stephen; Subramanian, G. Mani; Myers, Robert P.; Middleton, Michael S.; Rinella, Mary; Noureddin, Mazen

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

JOURNAL OF HEPATOLOGY

IF33

2020-07-01

306

PREAI

Harrison, Stephen A.; Wong, Vincent Wai-Sun; Okanoue, Takeshi; Bzowej, Natalie; Vuppalanchi, Raj; Younes, Ziad; Kohli, Anita; Sarin, Shiv; Caldwell, Stephen H.; Alkhouri, Naim; Shiffman, Mitchell L.; Camargo, Marianne; Li, Georgia; Kersey, Kathryn; Jia, Catherine; Zhu, Yanni; Djedjos, C. Stephen; Subramanian, G. Mani; Myers, Robert P.; Gunn, Nadege; Sheikh, Aasim; Anstee, Quentin M.; Romero-Gomez, Manuel; Trauner, Michael; Goodman, Zachary; Lawitz, Eric J.; Younossi, Zobair

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertension

JOURNAL OF HEPATOLOGY

IF33

2020-05-01

111

OAAI

Garcia-Tsao, Guadalupe; Bosch, Jaime; Kayali, Zeid; Harrison, Stephen A.; Abdelmalek, Manal F.; Lawitz, Eric; Satapathy, Sanjaya K.; Ghabril, Marwan; Shiffman, Mitchell L.; Younes, Ziad H.; Thuluvath, Paul J.; Berzigotti, Annalisa; Albillos, Agustin; Robinson, James M.; Hagerty, David T.; Chan, Jean L.; Sanyal, Arun J.

Effects of Belapectin, an Inhibitor of Galectin-3, in Patients With Nonalcoholic Steatohepatitis With Cirrhosis and Portal Hypertension Galectin-3抑制剂Belapectin对肝硬化和门脉高压的非酒精性脂肪性肝炎患者的影响

GASTROENTEROLOGY

IF25.1

2020-04-01

227

OAAI

Chalasani, Naga; Abdelmalek, Manal F.; Garcia-Tsao, Guadalupe; Vuppalanchi, Raj; Alkhouri, Naim; Rinella, Mary; Noureddin, Mazen; Pyko, Maxmillan; Shiffman, Mitchell; Sanyal, Arun; Allgood, Adam; Shlevin, Harold; Horton, Rex; Zomer, Eliezer; Irish, William; Goodman, Zachary; Harrison, Stephen A.; Traber, Peter G.

Reduction and stabilization of bilirubin with obeticholic acid treatment in patients with primary biliary cholangitis

LIVER INTERNATIONAL

IF5.2

2020-03-24

OAAI

Pares, Albert; Shiffman, Mitchell; Vargas, Victor; Invernizzi, Pietro; Malecha, Elizabeth S.; Liberman, Alexander; MacConell, Leigh; Hirschfield, Gideon

Sustained Improvements in Markers of Liver Disease Severity After Hepatitis C Treatment

clinical and experimental pediatrics

IF3.2

2020-03-01

OAAI

Wong, Robert J.; Jain, Mamta K.; Therapondos, George; Shiffman, Mitchell L.; Kshirsagar, Onkar; Clark, Christopher; Thamer, Mae

Durable response in the markers of cholestasis through 5 years of open-label extension study of obeticholic acid in primary biliary cholangitis

DIGESTIVE AND LIVER DISEASE

IF3.8

2020-02-01

PREAI

Nevens, F.; Shiffman, M. L.; Drenth, J. P. H.; Bowlus, C. L.; Vargas, V.; Andreone, P.; van Erpecum, K.; Floreani, A.; Liberman, A.; Pencek, R.; Malecha, E. Smoot; MacConell, L.; Trauner, M.

Efficacy of Glecaprevir and Pibrentasvir in Patients With Genotype 1 Hepatitis C Virus Infection With Treatment Failure After NS5A Inhibitor Plus Sofosbuvir Therapy

GASTROENTEROLOGY

IF25.1

2019-12-01

OAAI

Lok, Anna S.; Sulkowski, Mark S.; Kort, Jens J.; Willner, Ira; Reddy, K. Rajender; Shiffman, Mitchell L.; Hassan, Mohamed A.; Pearlman, Brian L.; Hinestrosa, Federico; Jacobson, Ira M.; Morelli, Giuseppe; Peter, Joy A.; Vainorius, Monika; Michael, Larry C.; Fried, Michael W.; Wang, Gary P.; Lu, Wenjing; Larsen, Lois; Nelson, David R.

研究方向